AI heart test may spot hidden danger in older cancer surgery patients

NCT ID NCT07634666

Recruiting now Knowledge-focused Sponsor: Korea University Anam Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 23, 2026 · Updated 3 times

Summary

This study will enroll 200 adults aged 60 or older who are scheduled for major surgery for urologic cancer. Researchers want to see if an artificial intelligence analysis of a standard heart test (ECG) taken before surgery can predict whether a patient will suffer heart injury or a major heart event within 30 days after the operation. No treatments or interventions are given—this is purely an observational study to gather information.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a simple, low-cost way to identify patients at high risk of heart complications after surgery, helping doctors take preventive steps.
What could go wrong: This is an observational study, not a treatment trial. It only looks at whether AI can predict risk—it does not test any intervention to reduce that risk. Results may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign urinary system neoplasm malignant urinary system neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE) MYOCARDIAL INJURY AFTER NON-CARDIAC SURGERY UROLOGIC CANCER

Contacts and locations

Locations

Seoul St. Mary's Hospital, The Catholic University of Korea
RECRUITING

Seoul, 06591, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.